...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BJU international >Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy
【24h】

Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy

机译：Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Objectives To review urinary protein biomarkers as potential non‐invasive, easily obtainable, early diagnostic tools in renal cell carcinoma (RCC). Methods A PubMed database search was performed up to the year 2020 to identify primary studies reporting potential urinary protein biomarkers for RCC. Separate searches were conducted to identify studies describing appropriate methods of developing cancer screening programmes and detection of cancer biomarkers. Results Several urinary protein biomarkers are under validation for RCC diagnostics, e.g. aquaporin‐1, perilipin‐2, carbonic anhydrase‐9, Raf‐kinase inhibitory protein, nuclear matrix protein‐22, 14‐3‐3 Protein β/α and neutrophil gelatinase‐associated lipocalin. However, none has yet been validated or approved for clinical use due to low sensitivity or specificity, inconsistencies in appropriate study design, or lack of external validation. Conclusions Evaluation of biomarkers’ feasibility, sample preparation and storage, biomarker validation, and the application of novel technologies may provide a solution that maximises the potential for a truly non‐invasive biomarker in early RCC diagnostics.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号